2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$14.84-$0.07 (-0.50%)
Price as of Nov 11, 2026 7:55 PM EST- $2.1BMarket Cap
- 23.22%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$14.84-$0.07 (-0.50%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.91 | ||
Change | -$0.40 (-2.61%) | ||
Open | $14.12 | ||
High | $15.25 | ||
Low | $13.64 | ||
Previous Close | $15.31 | ||
Volume | 2,322,968 | ||
30-Day Average Volume | 1,891,864 | ||
1-Week Change | 7.58% | ||
1-Month Change | 13.04% | ||
1-Year Change | 23.22% | ||
3-Year Change | 1,038.17% | ||
5-Year Change | 1,174.36% | ||
Fundamentals | |||
Shares Outstanding | 142.5M | ||
Total Assets | $310.8M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$21.5M | ||
Free Cash Flow | -$19.7M | ||
EBIT | -$21.5M | ||
EBITDA | -$21.4M | ||
Net Working Capital | $297.9M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -98 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -115 | ||
PEG | 6 | ||
Price/Free Cash Flow | -108 | ||
Price/Operating Cash Flow | -108 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue